[Long-term results with timolol].
The results of an 18-month study with Timolol in 36 patients with glaucoma or ocular hypertension are presented. Patients with ocular hypertension were well controlled with Timolol alone, while in the glaucoma group most patients needed combined treatment with a parasympathomimetic drug. Some trends suggest a continuous diminution of the hypotensive effect to Timolol, especially in the glaucoma group. No severe reactions were observed, although slight bradycardia could represent a risk for patients with severe heart conditions. Minor local and systemic side effects are mentioned.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D011412:Propanolamines / Q000627:therapeutic use*; D013999:Timolol / Q000009:adverse effects / Q000627:therapeutic use*
D011412:Propanolamines; D013999:Timolol
Langzeitresultate mit Timolol.